KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Profit After Tax (2016 - 2025)

Historic Profit After Tax for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $140.0 million.

  • West Pharmaceutical Services' Profit After Tax rose 294.12% to $140.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $491.7 million, marking a year-over-year decrease of 158.13%. This contributed to the annual value of $492.7 million for FY2024, which is 1697.0% down from last year.
  • As of Q3 2025, West Pharmaceutical Services' Profit After Tax stood at $140.0 million, which was up 294.12% from $131.8 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Profit After Tax ranged from a high of $188.5 million in Q2 2022 and a low of $89.8 million during Q1 2025
  • Over the past 5 years, West Pharmaceutical Services' median Profit After Tax value was $140.0 million (recorded in 2023), while the average stood at $141.9 million.
  • In the last 5 years, West Pharmaceutical Services' Profit After Tax skyrocketed by 11336.57% in 2021 and then tumbled by 3132.12% in 2022.
  • West Pharmaceutical Services' Profit After Tax (Quarter) stood at $147.7 million in 2021, then crashed by 30.26% to $103.0 million in 2022, then soared by 33.01% to $137.0 million in 2023, then decreased by 5.04% to $130.1 million in 2024, then increased by 7.61% to $140.0 million in 2025.
  • Its Profit After Tax stands at $140.0 million for Q3 2025, versus $131.8 million for Q2 2025 and $89.8 million for Q1 2025.